PLoS biology

Aging-related problems with cell structures that process fats affect intestinal stem cell development

Updated

Abstract

Reduced PEX5 expression in aged intestinal stem cells leads to (VLCFAs) accumulation.

  • Aging disrupts the integrity of intestinal stem cell lineage, affecting epithelial barrier function.
  • Peroxisomal dysfunction is identified as a key factor in age-related intestinal stem cell mis-differentiation.
  • RAB7-dependent late endosome maturation and SOX21A are involved in the regulation of aged intestinal stem cell differentiation.
  • Aspirin appears to restore lineage fidelity in intestinal stem cells by enhancing peroxisomal breakdown of VLCFAs.
  • These findings point to peroxisomal function and VLCFA metabolism as important elements in the aging process of intestinal stem cells.

Simplified

Key numbers

31 of 31
Decrease in pre-enterocyte cells
Ratios of progenitor cells and pre-enterocytes significantly decreased after Aspirin treatment.
20 days
Aspirin treatment duration
Aspirin was administered for 20 days to assess its effects on ISC differentiation.
3 months
Aging mouse duration
Aged mice were treated with Aspirin for 3 months to evaluate its impact on intestinal health.

Full Text

What this is

  • Aging impairs intestinal stem cell (ISC) function, leading to health decline.
  • Peroxisomal dysfunction is identified as a key factor in age-related .
  • Aspirin restores ISC lineage fidelity by enhancing peroxisomal function, particularly through PEX5-mediated β-oxidation of ().

Essence

  • Aging disrupts intestinal stem cell differentiation due to peroxisomal dysfunction. Aspirin treatment enhances peroxisomal function, improving ISC lineage fidelity and potentially offering therapeutic strategies against age-related intestinal decline.

Key takeaways

  • Aging leads to decreased PEX5 expression in ISCs, resulting in impaired peroxisomal function and accumulation of . This accumulation is linked to , which contributes to intestinal dysfunction.
  • Aspirin treatment enhances PEX5-mediated peroxisomal function, reducing VLCFA levels and restoring ISC differentiation. This suggests that aspirin may serve as a therapeutic agent for age-related intestinal decline.
  • Increased abundance of in aged ISCs correlates with decreased functionality, indicating that peroxisomal health is crucial for maintaining ISC differentiation and intestinal health during aging.

Caveats

  • The study primarily uses Drosophila and mouse models, which may not fully replicate human aging processes. Further research is needed to confirm these findings in human subjects.
  • Variability in aspirin concentrations and treatment duration across species may affect the generalizability of the results. Standardized protocols are necessary for clinical applications.

Definitions

  • Peroxisomes: Subcellular organelles involved in lipid metabolism and reactive oxygen species detoxification.
  • Very Long-Chain Fatty Acids (VLCFAs): Fatty acids containing 20 or more carbon atoms, primarily oxidized in peroxisomes.
  • ISC mis-differentiation: Impaired differentiation of intestinal stem cells, leading to abnormal cell lineage and function.

Simplified

Funding

Competing interests

The authors have declared that no competing interests exist.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free